Tango Therapeutics to Participate in 2026 Cantor Global Healthcare Conference
News provided byTango Therapeutics, Inc · 1 min read
BOSTON, Sept. 01, 2026 /CourierPR/ -- Tango Therapeutics, a clinical-stage biotechnology company focused on precision medicine for cancer treatment, will participate in a fireside chat at the 2026 Cantor Global Healthcare Conference on Wednesday, September 9, 2026, at 8:35 AM EDT.
The company's management team will share insights on their latest developments and future strategies during the event. Attendees can tune in to the live webcast, which will be accessible via the "Events & Presentations" section on Tango Therapeutics' "Investors" page. The webcast will also be archived on the company's website for 90 days following the presentation.
Tango Therapeutics, headquartered in San Diego, California, aims to advance its mission of developing novel drug targets through an approach rooted in patient-centric research. The company uses the genetic principle of synthetic lethality to identify and create therapies targeting critical cancer pathways. For more information on Tango Therapeutics, visit their website at www.tangotx.com.
The event offers a platform for the biotech firm to engage with stakeholders and investors, showcasing their progress and plans for the future.